Skip to main content
Jeffrey Bender, MD, Cardiology, New Haven, CT, Yale-New Haven Hospital

JeffreyRobertBenderMD

Cardiology • New Haven, CT

Preventive Cardiology

Robert I. Levy Prof. of Cardiology, Director Yale Cardiovascular Research Center, Assoc. Chief, Cardiovascular Medicine, Yale U. School. of Medicine

Join to view full profile

Dr. Bender is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bender's full profile

Already have an account?

Education & Training

  • Stanford Health Care
    Stanford Health CarePost-Doctoral Fellowship, Molecular Immunology, 1984 - 1988
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1983 - 1986
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterChief Residency, Internal Medicine, 1982 - 1983
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1979 - 1982
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1979

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1988 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • President Association of University Cardiologists, 2013
  • Elected member Association of American Physicians, 2002
  • Robert I. Levy Endowed Professorship Yale University, 2002
  • Join now to see all

Publications & Presentations

PubMed

Grant Support

  • Vascular disease pathogenesis: interface between smooth muscle and immune cellsNIH2018–2023
  • Competitive Macrophage MicroRNA-RNA Binding Protein Interactions in Wound RepairNIH2017–2022
  • Therapeutic miRNA target site blocking oligonucleotide in autoimmune/inflammatory diseaseBlavatnik Fund for Innovation2018–2020
  • Therapeutic inhibition of MIF to restore glucocorticoid responseNIH2017–2019
  • Modulating Neuroinflammation through interference of cooperative microRNA - RNA-binding protein interactionsNIH2016–2018
  • Macrophage integrin-modulated RNA stability in neovessel formationState of Connecticut Public Health2015–2018
  • Molecular Models Of Estrogen-Induced Vascular ProtectionNational Heart, Lung, And Blood Institute2003–2011
  • Vascular Research TrainingNational Heart, Lung, And Blood Institute2000–2011
  • Molecular Models Of Immune-Mediated Vascular InjuryNational Heart, Lung, And Blood Institute1994–2011
  • An Ifn-Y-Integrin-Growth Factor Axis In GA Biomarker DevelopmentNational Heart, Lung, And Blood Institute2006–2010
  • Molecular Models Of Estrogen-Induced Vascular ProtectionNational Heart, Lung, And Blood Institute2007
  • Imaging DTH, IFN Gamma Responses &Ga In Human ArteriesNational Heart, Lung, And Blood Institute2001–2005
  • Contact Dependent Endothelial Activation By NK CellsNational Heart, Lung, And Blood Institute1999–2003
  • Molecular Models Of Estrogen Induced Vascular ProtectionNational Heart, Lung, And Blood Institute1999–2002
  • Molecular Models Of Immune Mediated Vascular InjuryNational Heart, Lung, And Blood Institute1991–2001
  • Contact Dependent Endothelial HLA Induction By NK CellsNational Heart, Lung, And Blood Institute1995–1998
  • Lymphocyte--Endothelial Cell Molecular InteractionsNational Heart, Lung, And Blood Institute1988–1991
  • T Lymphocytes In Human Heart Transplant RejectionNational Heart, Lung, And Blood Institute1985

Hospital Affiliations

Dr. Jeffrey Bender, Dr. Jeffrey Bender, MD, Dr. J Bender, Dr. Jeffrey Robert Bender